D

Duopharma Biotech Bhd
KLSE:DPHARMA

Watchlist Manager
Duopharma Biotech Bhd
KLSE:DPHARMA
Watchlist
Price: 1.25 MYR -0.79% Market Closed
Market Cap: 1.2B MYR
Have any thoughts about
Duopharma Biotech Bhd?
Write Note

Duopharma Biotech Bhd
Total Equity

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
|

Duopharma Biotech Bhd
Total Equity Peer Comparison

Competitors Analysis
Latest Figures & CAGR of Competitors

Company Total Equity CAGR 3Y CAGR 5Y CAGR 10Y
D
Duopharma Biotech Bhd
KLSE:DPHARMA
Total Equity
myr696m
CAGR 3-Years
4%
CAGR 5-Years
6%
CAGR 10-Years
14%
P
PeterLabs Holdings Bhd
KLSE:PLABS
Total Equity
myr78.9m
CAGR 3-Years
4%
CAGR 5-Years
9%
CAGR 10-Years
10%
A
Apex Healthcare Bhd
KLSE:AHEALTH
Total Equity
myr918.3m
CAGR 3-Years
24%
CAGR 5-Years
17%
CAGR 10-Years
14%
R
Rhone Ma Holdings Bhd
KLSE:RHONEMA
Total Equity
myr166.9m
CAGR 3-Years
9%
CAGR 5-Years
9%
CAGR 10-Years
N/A
Y
YSP Southeast Asia Holding Bhd
KLSE:YSPSAH
Total Equity
myr397.9m
CAGR 3-Years
6%
CAGR 5-Years
5%
CAGR 10-Years
6%
K
Kotra Industries Bhd
KLSE:KOTRA
Total Equity
myr285.2m
CAGR 3-Years
9%
CAGR 5-Years
10%
CAGR 10-Years
9%
No Stocks Found

Duopharma Biotech Bhd
Glance View

Market Cap
1.2B MYR
Industry
Pharmaceuticals

Duopharma Biotech Bhd.is an investment holding company, which engages in the manufacturing and distribution of pharmaceutical products. The company is headquartered in Klang, Selangor. The company went IPO on 2002-07-18. The Company, through its subsidiaries is engaged in manufacturing, distribution, importing and exporting of pharmaceutical products and medicines. The firm also engaged in research and development of pharmaceutical products. Its subsidiaries include Duopharma (M) Sendirian Berhad, Duopharma Manufacturing (Bangi) Sdn. Bhd., Duopharma Marketing Sdn. Bhd., Duopharma Consumer Healthcare Sdn. Bhd., Duopharma HAPI Sdn. Bhd., Duopharma Innovation Sdn. Bhd., Unique Pharmacy (Penang) Sdn. Bhd., Sentosa Pharmacy Sdn. Bhd., Duopharma Manufacturing (Glenmarie) Sdn. Bhd., Negeri Pharmacy Sdn. Bhd., Duopharma (Singapore) Pte. Ltd. and DB (Philippines), Inc.

DPHARMA Intrinsic Value
1.69 MYR
Undervaluation 26%
Intrinsic Value
Price
D

See Also

What is Duopharma Biotech Bhd's Total Equity?
Total Equity
696m MYR

Based on the financial report for Sep 30, 2024, Duopharma Biotech Bhd's Total Equity amounts to 696m MYR.

What is Duopharma Biotech Bhd's Total Equity growth rate?
Total Equity CAGR 10Y
14%

Over the last year, the Total Equity growth was 3%. The average annual Total Equity growth rates for Duopharma Biotech Bhd have been 4% over the past three years , 6% over the past five years , and 14% over the past ten years .

Back to Top